Snord 3A: a molecular marker and modulator of prion disease progression.
Since preventive treatments for prion disease require early identification of subjects at risk, we searched for surrogate peripheral markers characterizing the asymptomatic phases of such conditions. To this effect, we subjected blood mRNA from E200K PrP CJD patients and corresponding family members...
Main Authors: | Eran Cohen, Dana Avrahami, Kati Frid, Tamar Canello, Ephrat Levy Lahad, Sharon Zeligson, Shira Perlberg, Joab Chapman, Oren S Cohen, Esther Kahana, Iris Lavon, Ruth Gabizon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3549992?pdf=render |
Similar Items
-
Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease
by: Tamar Canello, et al.
Published: (2012-03-01) -
Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease.
by: Yael Friedman-Levi, et al.
Published: (2011-11-01) -
Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease.
by: Yael Friedman-Levi, et al.
Published: (2017-05-01) -
Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis.
by: Silvina Epsztejn-Litman, et al.
Published: (2015-01-01) -
Mitochondrial dysfunction in preclinical genetic prion disease: A target for preventive treatment?
by: Guy Keller, et al.
Published: (2019-04-01)